Non-invasive Prenatal Testing (NIPT) Market Size, Share, Global Analysis and Opportunity Assessment 2020-2027

                                                                                   
Noninvasive prenatal testing (NIPT), also known as noninvasive prenatal screening (NIPS), is a technique for estimating the likelihood that a foetus may be born with genetic abnormalities

Non-invasive Prenatal Testing (NIPT) Market


Noninvasive prenatal testing (NIPT), also known as noninvasive prenatal screening (NIPS), is a technique for estimating the likelihood that a foetus may be born with genetic abnormalities. Small bits of DNA circulating in a pregnant woman's blood are analysed in this test. Unlike most DNA, which is located inside a cell's nucleus, these pieces are free-floating and are referred to as cell-free DNA since they are not contained within cells (cfDNA). When cells die and are broken down, their contents, including DNA, are released into the circulation, these little fragments form. They normally comprise fewer than 200 DNA building blocks (base pairs).

One of the primary reasons driving market expansion is the rising occurrence of foetal genetic diseases. Additionally, technological improvements in the realm of life sciences and the healthcare business are boosting the Non-invasive Prenatal Testing Market. The development of DNA sequencing technology, regenerative therapies, and advancements in molecular research, for example, have opened up enormous potential for combating the risk of any catastrophic disease in its earliest stages. Additionally, the market is being driven by an increasing acceptance rate for prenatal testing, as well as rising health consciousness and understanding about the benefits and significance of such testing among the general public. Alternatives are being adopted by healthcare practitioners and expectant parents to identify and treat additional genetic abnormalities, such as spina bifida, cleft palate, and sickle cell anaemia, in the early stages of foetal development.

Furthermore, the changing tendency toward childbearing at an advanced mother age (35 years or older) is boosting market growth. Increasing maternal age can contribute to a variety of health issues, including high blood pressure, decreased fertility, a higher risk of miscarriage, and a higher risk of genetic abnormalities in the foetus.


Market Segmentation:

By Test Type

  • Panel 1 Test
  • Panel 2 Test
  • Panel 3 Test

By End User
  • Hospitals
  • Diagnostic Laboratories
  • Maternity Centers

The major players operating in the global non-invasive prenatal testing market include, Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women’s Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated.

Comments

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.